Octreotid-Mepha LA 10 mg
Octreotid-Mepha LA 10 mg is a medicine authorised by Swissmedic under authorisation number 67154. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 19 July 2019 and the authorisation is valid without a time limit. ATC code H01CB02 places the medicine in the group Pituitary and hypothalamic hormones and analogues.
| Authorisation number | 67154 |
|---|---|
| Name | Octreotid-Mepha LA 10 mg |
| Full name | Octreotid-Mepha LA 10 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | H01CB02 |
| First authorisation | 19 July 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Octreotid-Mepha LA 10 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | A | 19 July 2019 |
| 2 | Octreotid-Mepha LA 20 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | A | 19 July 2019 |
| 3 | Octreotid-Mepha LA 30 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | A | 19 July 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | H01CB02 | 07.16.2. | A |
| 2 | 1 | Durchstechflasche(n) | H01CB02 | 07.16.2. | A |
| 3 | 1 | Durchstechflasche(n) | H01CB02 | 07.16.2. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Octreotid-Mepha LA 10 mg authorised in Switzerland?
Yes. Octreotid-Mepha LA 10 mg is authorised by Swissmedic under authorisation number 67154, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Octreotid-Mepha LA 10 mg have?
Octreotid-Mepha LA 10 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Octreotid-Mepha LA 10 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.